Pharmedica has an exclusive license for the proven and patented Orally Dissolving Film (ODF) platform technology. It provides a unique oral dosage form film system for administration of active pharmaceutical ingredients into the systemic circulation through the oral buccal mucosa. Due to its permeability it is the preferred site for retentive oral transmucosal delivery systems and for sustained and controlled-release delivery devices.